136 related articles for article (PubMed ID: 17207559)
1. Development of a rat parathyroid hormone 2 receptor antagonist.
Kuo J; Usdin TB
Peptides; 2007 Apr; 28(4):887-92. PubMed ID: 17207559
[TBL] [Abstract][Full Text] [Related]
2. Molecular determinants of tuberoinfundibular peptide of 39 residues (TIP39) selectivity for the parathyroid hormone-2 (PTH2) receptor. N-terminal truncation of TIP39 reverses PTH2 receptor/PTH1 receptor binding selectivity.
Hoare SR; Clark JA; Usdin TB
J Biol Chem; 2000 Sep; 275(35):27274-83. PubMed ID: 10854439
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors.
Hoare SR; Usdin TB
Curr Pharm Des; 2001 May; 7(8):689-713. PubMed ID: 11375776
[TBL] [Abstract][Full Text] [Related]
4. High affinity binding of the peptide agonist TIP-39 to the parathyroid hormone 2 (PTH
Weaver RE; Mobarec JC; Wigglesworth MJ; Reynolds CA; Donnelly D
Biochem Pharmacol; 2017 Mar; 127():71-81. PubMed ID: 28012961
[TBL] [Abstract][Full Text] [Related]
5. Tuberoinfundibular peptide (7-39) [TIP(7-39)], a novel, selective, high-affinity antagonist for the parathyroid hormone-1 receptor with no detectable agonist activity.
Hoare SR; Usdin TB
J Pharmacol Exp Ther; 2000 Nov; 295(2):761-70. PubMed ID: 11046116
[TBL] [Abstract][Full Text] [Related]
6. Regions in rat and human parathyroid hormone (PTH) 2 receptors controlling receptor interaction with PTH and with antagonist ligands.
Goold CP; Usdin TB; Hoare SR
J Pharmacol Exp Ther; 2001 Nov; 299(2):678-90. PubMed ID: 11602681
[TBL] [Abstract][Full Text] [Related]
7. Transcript expression of the tuberoinfundibular peptide (TIP)39/PTH2 receptor system and non-PTH1 receptor-mediated tonic effects of TIP39 and other PTH2 receptor ligands in renal vessels.
Eichinger A; Fiaschi-Taesch N; Massfelder T; Fritsch S; Barthelmebs M; Helwig JJ
Endocrinology; 2002 Aug; 143(8):3036-43. PubMed ID: 12130570
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the ligand specificity of zebrafish parathyroid hormone (PTH) receptors: comparison of PTH, PTH-related protein, and tuberoinfundibular peptide of 39 residues.
Hoare SR; Rubin DA; Jüppner H; Usdin TB
Endocrinology; 2000 Sep; 141(9):3080-6. PubMed ID: 10965877
[TBL] [Abstract][Full Text] [Related]
9. Tuberoinfundibular peptide of 39 residues: a new mediator of cardiac function via nitric oxide production in the rat heart.
Ross G; Engel P; Abdallah Y; Kummer W; Schluter KD
Endocrinology; 2005 May; 146(5):2221-8. PubMed ID: 15677763
[TBL] [Abstract][Full Text] [Related]
10. PTH2 receptor-mediated inhibitory effect of parathyroid hormone and TIP39 on cell proliferation.
Misiano P; Scott BB; Scheideler MA; Garnier M
Eur J Pharmacol; 2003 May; 468(3):159-66. PubMed ID: 12754053
[TBL] [Abstract][Full Text] [Related]
11. The parathyroid hormone 2 (PTH2) receptor.
Usdin TB; Bonner TI; Hoare SR
Recept Channels; 2002; 8(3-4):211-8. PubMed ID: 12529938
[TBL] [Abstract][Full Text] [Related]
12. The TIP39-PTH2 receptor system: unique peptidergic cell groups in the brainstem and their interactions with central regulatory mechanisms.
Dobolyi A; Palkovits M; Usdin TB
Prog Neurobiol; 2010 Jan; 90(1):29-59. PubMed ID: 19857544
[TBL] [Abstract][Full Text] [Related]
13. Comparison of rat and human parathyroid hormone 2 (PTH2) receptor activation: PTH is a low potency partial agonist at the rat PTH2 receptor.
Hoare SR; Bonner TI; Usdin TB
Endocrinology; 1999 Oct; 140(10):4419-25. PubMed ID: 10499494
[TBL] [Abstract][Full Text] [Related]
14. Structure of tuberoinfundibular peptide of 39 residues.
Piserchio A; Usdin T; Mierke DF
J Biol Chem; 2000 Sep; 275(35):27284-90. PubMed ID: 10856302
[TBL] [Abstract][Full Text] [Related]
15. Centrally administered tuberoinfundibular peptide of 39 residues inhibits arginine vasopressin release in conscious rats.
Sugimura Y; Murase T; Ishizaki S; Tachikawa K; Arima H; Miura Y; Usdin TB; Oiso Y
Endocrinology; 2003 Jul; 144(7):2791-6. PubMed ID: 12810532
[TBL] [Abstract][Full Text] [Related]
16. Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociception.
Dobolyi A; Ueda H; Uchida H; Palkovits M; Usdin TB
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1651-6. PubMed ID: 11818570
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the human and mouse genes encoding the tuberoinfundibular peptide of 39 residues, a ligand of the parathyroid hormone receptor family.
Hansen IA; Jakob O; Wortmann S; Arzberger T; Allolio B; Blind E
J Endocrinol; 2002 Jul; 174(1):95-102. PubMed ID: 12098667
[TBL] [Abstract][Full Text] [Related]
18. Tuberoinfundibular peptide of 39 residues (TIP39): molecular structure and activity for parathyroid hormone 2 receptor.
Della Penna K; Kinose F; Sun H; Koblan KS; Wang H
Neuropharmacology; 2003 Jan; 44(1):141-53. PubMed ID: 12559132
[TBL] [Abstract][Full Text] [Related]
19. Tuberoinfundibular peptide 39 binds to the parathyroid hormone (PTH)/PTH-related peptide receptor, but functions as an antagonist.
Jonsson KB; John MR; Gensure RC; Gardella TJ; Jüppner H
Endocrinology; 2001 Feb; 142(2):704-9. PubMed ID: 11159842
[TBL] [Abstract][Full Text] [Related]
20. Vasodilatory effect of tuberoinfundibular peptide (TIP39): requirement of receptor desensitization and its beneficial effect in the post-ischemic heart.
Ross G; Heinemann MP; Schlüter KD
Peptides; 2007 Apr; 28(4):878-86. PubMed ID: 17222942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
